These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 36128282)

  • 1. Effectiveness of Plasmapheresis Treatment in the Treatment of Patients with COVID-19 Disease.
    Khodakarim N; Kalantari S; Riahi T; Moradians V; Talebi-Taher M; Yassin Z; Afshar H; Kooranifar S; Aloosh O; Ziaie S; Zamani N; Tirkan A; Ramim T
    Med J Islam Repub Iran; 2022; 36():83. PubMed ID: 36128282
    [No Abstract]   [Full Text] [Related]  

  • 2. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmapheresis reduces cytokine and immune cell levels in COVID-19 patients with acute respiratory distress syndrome (ARDS).
    Hashemian SM; Shafigh N; Afzal G; Jamaati H; Tabarsi P; Marjani M; Malekmohammad M; Mortazavi SM; Khoundabi B; Mansouri D; Moniri A; Hajifathali A; Roshandel E; Mortaz E; Adcock IM
    Pulmonology; 2021; 27(6):486-492. PubMed ID: 33358260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Double-blind, randomized, controlled, trial to assess the efficacy of allogenic mesenchymal stromal cells in patients with acute respiratory distress syndrome due to COVID-19 (COVID-AT): A structured summary of a study protocol for a randomised controlled trial.
    Payares-Herrera C; Martínez-Muñoz ME; Vallhonrat IL; de Molina RM; Torres MP; Trisan A; de Diego IS; Alonso R; Zafra R; Donaire T; Sánchez R; Rubio JJ; Duarte Palomino RF; Solá CA
    Trials; 2021 Jan; 22(1):9. PubMed ID: 33407777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SPIKE-1: A Randomised Phase II/III trial in a community setting, assessing use of camostat in reducing the clinical progression of COVID-19 by blocking SARS-CoV-2 Spike protein-initiated membrane fusion.
    Halford S; Wan S; Dragoni I; Silvester J; Nazarov B; Anthony D; Anthony S; Ladds E; Norrie J; Dhaliwal K;
    Trials; 2021 Aug; 22(1):550. PubMed ID: 34412682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Characteristics and Factors Associated with Poor Outcomes in Hospitalized Patients with Novel Coronavirus Infection COVID-19.
    Boytsov SA; Pogosova NV; Paleev FN; Ezhov MV; Komarov AL; Pevsner DV; Gruzdev KA; Barinova IV; Suvorov AY; Alekseeva IA; Milko OV
    Kardiologiia; 2021 Mar; 61(2):4-14. PubMed ID: 33734042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiviral and immunomodulatory interferon-beta in high-risk COVID-19 patients: a structured summary of a study protocol for a randomised controlled trial.
    Aricò E; Castiello L; Bracci L; Urbani F; Lombardo F; Bacigalupo I; Ancidoni A; Vanacore N; Falcione A; Reggiani C; Dutti GM; Maglie MG; Papa O; Bartoletti PL; Ozzella G; Bevilacqua N; Nicastri E; Belardelli F; Sconocchia G
    Trials; 2021 Sep; 22(1):584. PubMed ID: 34479601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective, randomized, controlled study assessing vagus nerve stimulation using the gammaCore®-Sapphire device for patients with moderate to severe CoViD-19 Respiratory Symptoms (SAVIOR): A structured summary of a study protocol for a randomised controlled trial".
    Tornero C; Vallejo R; Cedeño D; Orduña J; Pastor E; Belaouchi M; Escamilla B; Laredo M; Del Mar Garzando M
    Trials; 2020 Jun; 21(1):576. PubMed ID: 32586395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proactive anti-inflammatory therapy with colchicine in the treatment of advanced stages of new coronavirus infection. The first results of the COLORIT study.
    Mareev VY; Orlova YA; Plisyk AG; Pavlikova EP; Akopyan ZA; Matskeplishvili ST; Malakhov PS; Krasnova TN; Seredenina EM; Potapenko AV; Agapov MA; Asratyan DA; Dyachuk LI; Samokhodskaya LM; Mershina ЕА; Sinitsyn VE; Pakhomov PV; Zhdanova EA; Mareev YV; Begrambekova YL; Kamalov АА
    Kardiologiia; 2021 Mar; 61(2):15-27. PubMed ID: 33734043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An investigation into the beneficial effects of high-dose interferon beta 1-a, compared to low-dose interferon beta 1-a (the base therapeutic regimen) in moderate to severe COVID-19: A structured summary of a study protocol for a randomized controlled l trial.
    Alavi Darazam I; Hatami F; Rabiei MM; Pourhoseingholi MA; Moradi O; Shokouhi S; Hajesmaeili MR; Shabani M; Irvani SSN
    Trials; 2020 Oct; 21(1):880. PubMed ID: 33106183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasmapheresis with corticosteroids and antiviral: a life-saving treatment for severe cases of Covid 19.
    Bagherzade M; Parham M; Zohali S; Molaei S; Vafaeimanesh J
    Caspian J Intern Med; 2020; 11(Suppl 1):572-576. PubMed ID: 33425279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits of Tocilizumab in patients with a severe form of SARS-CoV-2 infection: Experience of the intensive care unit of the Mohammed VI university hospital, Oujda.
    El Rhalete A; Rhazi I; Bensaid A; Diass S; Kaouini A; Ounci E; Abdi M; Maarad M; Babouh C; Alami Z; Abda N; Bkiyer H; Housni B
    Ann Med Surg (Lond); 2021 Jul; 67():102514. PubMed ID: 34221397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Assessment of the effectiveness of early treatment in SARS-CoV-2 infection].
    Płusa T
    Pol Merkur Lekarski; 2021 Dec; 49(294):394-400. PubMed ID: 34919080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial.
    Panda PK; Bandyopadhyay A; Singh BC; Moirangthem B; Chikara G; Saha S; Bahurupi YA
    Trials; 2020 Oct; 21(1):866. PubMed ID: 33081849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial.
    Irvani SSN; Golmohammadi M; Pourhoseingholi MA; Shokouhi S; Darazam IA
    Trials; 2020 Jun; 21(1):473. PubMed ID: 32493468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperbaric oxygen therapy may be effective to improve hypoxemia in patients with severe COVID-2019 pneumonia: two case reports.
    Guo D; Pan S; Wang M; Guo Y
    Undersea Hyperb Med; 2020; 47(2):181-187. PubMed ID: 32574433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of add-on therapy of Phyllanthus Emblica (Amla) on laboratory confirmed COVID-19 Cases: A randomized, double-blind, controlled trial.
    Varnasseri M; Siahpoosh A; Hoseinynejad K; Amini F; Karamian M; Yad MJY; Cheraghian B; Khosravi AD
    Complement Ther Med; 2022 May; 65():102808. PubMed ID: 35093510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In COVID-19 Patients, the Identified Gastrointestinal Symptoms in Tertiary Care Center of India.
    Murugesan M; Govindarajan R; Prakash L; Murugan CK; Jasmine JJ; Krishnasamy N
    Euroasian J Hepatogastroenterol; 2022; 12(1):24-30. PubMed ID: 35990860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.